Analysis of screening results of cervical cancer in rural middle-aged and elderly women in the southern part of Dongying City from 2015 to 2016
Li Longxin1,2, Li Qingchun1
1 Department of Reproductive Medicine,Binzhou Medical University Hospital,Binzhou 256603,China; 2 Obstetrics Department, The Second People's Hospital of Dongying City
Abstract：Objective To evaluate the value of liquid-based cytology, high-risk human papilloma virus detection and combined detection in cervical cancer screening.Methods From May 2015 to October 2016, 9 982 middle-aged and elderly rural women who were married or had sexual life history in the southern region of dongying were screened for cervical cancer free of charge after publicity. Gynecological examination, cervical liquid-based thin layer cytology test and high-risk HPV 12+2 typing test were performed first. For TCT positive, HPV positive and both positive cases, further colposcopy and cervical multi-point biopsy and cervical tube scratch pathology examination、 And the establishment of electronic personal files, and township hospitals to establish a two-way feedback mechanism, regular follow-up.Results TCT+HPV combined detection in CIN the positive expression rate of rise, according to the pathological changes degree aggravating in CIN Ⅲ reached 70.81%, reached 100% in SCC. As a screening method for cervical cancer, the detection rate of HPV combined with TCT in CIN is significantly higher than that of TCT alone or HPV alone. HPV combined with TCT can significantly improve the detection rate of cervical cancer prelesions.Conclusion In the screening of cervical lesions, TCT combined with HPV detection can significantly improve the positive rate of cervical lesions, effectively reduce the incidence of cervical cancer in middle-aged and elderly women in the south of Dongying, and can be widely used in clinical practice.
李龙欣, 李清春. 2015—2016年东营市南部地区农村中老年妇女宫颈癌筛查结果分析[J]. 中国医院统计, 2019, 26(1): 65-68.
Li Longxin, Li Qingchun. Analysis of screening results of cervical cancer in rural middle-aged and elderly women in the southern part of Dongying City from 2015 to 2016. journal1, 2019, 26(1): 65-68.
[1] 许剑利,徐克惠.高危型 HPV 检测及TCT 检查在宫颈癌筛查中的应用分析[J].实用妇产科杂志 2014,12(30): 946-949. [2] TARALLO PA,SMOLOWITZ J,CARRIERO D,et al.Prevalence of high risk human papillomavirus among women with hepatitis C virus before liver transplantation [J].Transpl Infect Dis,2013,15(4):400-404. [3] 楼玲芳. 液基薄层细胞学检测和高危型人乳头状瘤病毒检测在宫颈癌及癌前病变筛查和预后判断中的应用价值[J].中国医师进修杂志,2013,36(15):41-43. [4] The American College of Obstetricians and Gynecologists. CervicalCancer Screening and Prevention[J].Obstet Gy-necol,2016,127(1):1-20. [5] 王春芳,郑莹,顾凯,等.上海地区女性宫颈脱落细胞筛查工作的实施及其影响因素[J].环境与职业医学,2010,27(6):337. [6] 吴玉萍,王国平.液基细胞学和 HPV 原位杂交检测及其联合应用在子宫颈癌筛查中的作用[J].临床与实验病理学杂志,2010,26(4):402-406. [7] PARKIN DM, BRAY F, FERLAY J,et al. Global cancer statistics,2002[J]. CA Cancer J Clin,2005,55(2):74-108. [8] 赵培玉, 陈敖峥, 秦锦龙, 等.Cervista HR-HPV DNA 检测联合TCT 在宫颈癌筛查中的临床价值[J].检验医学,2017,32(4):322-325. [9] 赵超,赵昀,崔淑慧,等.子宫颈液基细胞学、高危型 HPV 及联合检测在子宫颈癌机会性筛查中的价值 [J].中国妇产科临床杂志,2016, 17(2):119-121. [10]吴小平,林美丽.高危型HPV检测联合TCT在宫颈癌筛查中的应用[J].中国医药科学,2014,4(22):110-111. [11]陈婉,王金英,林菲,等.高危型HPV-DNA检测联合TCT在基层妇女健康普查中的应用[J].中国当代医药,2017,24(5):48-50. [12]KOLIOPOULOS G, NYAGA VN, SANTESSO N, et al. Cytology versus HPV testing for cervical cancer screening in the general population[M]. John Wiley & Sons, Ltd,2010. [13]臧元怡.高危HPV检测联合TCT 在宫颈癌筛查中的应用[J].现代中西医结合杂志, 2015,24(11):1184-1186. [14]钱德英,岑坚敏,王丁,等.高危型人乳头状瘤病毒DNA检测与细胞学联合检查对子宫颈癌前病变筛查的研究[J].中华妇产科杂志,2006,41(1):34-37.
